KEVIN K.W. WANG, PH.D.
Center Director, Center of Innovative Research
Founder & Chief Scientific Officer, Banyan Biomarkers

Dr. Wang obtained his Ph.D. in Pharmaceutical Sciences with Distinction from the University of British Columbia in Vancouver in 1989. Dr. Wang is internationally recognized for his original contributions to the fields of CNS disorders-linked proteolytic enzymes, neuroproteomics and disease biomarker discovery. He joined Parke-Davis Pharmaceutical Research (Ann Arbor, MI) in 1991, and following the company's merger with Pfizer Inc.(2000), he became Group Leader of CNS Therapeutics and chaired the multidisciplinary CNS new targets team. He also co-chaired the Far East Scientific Opportunity Team involved in exploring values of traditional herbal medicine. He published more than 150 peer-reviewed papers, reviews and book chapters and co-authored eight US patents. He co-edited two books entitled "Calpain: the Pharmacology and Toxicology of a Calcium-dependent Protease" (2000) and "Neuroproteomic Methods" (2009), respectively. He is on the Editorial Boards of the journal Cell & Molecular Biology Letter and the Journal of Neurotrauma. In 2002, he became Associate Professor of Psychiatry and Neuroscience at the McKnight Brian Institute of the University of Florida (Gainesville, FL). He also served as Associate Director of the Center for Traumatic Brain Injury Studies and Director of the Center of Neuroproteomics and Biomarkers Research. In 2002, he co-founded Banyan Biomarkers Inc. (Alachua, Florida). In 2007, he transitioned to Banyan as full-time Chief Scientific Officer and the Center Director of the Center of Innovative Research. He also continues his academic affiliation at University of Florida as Courtesy Associate Professor of Psychiatry and Neuroscience.